ArticleFrontiers in endocrinology2022

Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.

Jian-Hong Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.